Search research articles
Contact Us
Filters
Showing results (1201-1210 of 1,303) with videos related to
Page
of 131
Sort By:
The Lancet. Neurology
|
May 31, 2014
Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial
Adam L Boxer, Anthony E Lang, Murray Grossman, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
February 8, 2024
Plasma biomarkers of Alzheimer's disease in the continuum of dementia with Lewy bodies
Patricia Diaz-Galvan, Scott A Przybelski, Alicia Algeciras-Schimnich, et al.
Neurology
|
May 18, 2023
β-Amyloid Load on PET Along the Continuum of Dementia With Lewy Bodies
Patricia Diaz-Galvan, Scott A Przybelski, Timothy G Lesnick, et al.
Clinical Pharmacology and Therapeutics
|
July 7, 2021
Adverse Cardiovascular Outcomes and Antihypertensive Treatment: A Genome-Wide Interaction Meta-Analysis in the International Consortium for Antihypertensive Pharmacogenomics Studies
Caitrin W McDonough, Helen R Warren, John R Jack, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
February 11, 2026
AI-enhanced Centiloid quantification of amyloid PET images
Pierrick Bourgeat, Jurgen Fripp, Leo Lebrat, et al.
JAMA Neurology
|
September 15, 2025
Plasma Phosphorylated Tau 217 to Identify Preclinical Alzheimer Disease
Gemma Salvadó, Shorena Janelidze, Divya Bali, et al.
Acta Neuropathologica
|
March 13, 2024
Role of GBA variants in Lewy body disease neuropathology
Ronald L Walton, Shunsuke Koga, Alexandra I Beasley, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 1, 2024
Prediction of future cognitive decline among cognitively unimpaired individuals using measures of soluble phosphorylated tau or tau tangle pathology
Rik Ossenkoppele, Gemma Salvadó, Shorena Janelidze, et al.
Nature Aging
|
March 29, 2025
Plasma p-tau217 and tau-PET predict future cognitive decline among cognitively unimpaired individuals: implications for clinical trials
Rik Ossenkoppele, Gemma Salvadó, Shorena Janelidze, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
March 26, 2016
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
Bruno Dubois, Harald Hampel, Howard H Feldman, et al.
Page
of 131
Search research articles
Search
Showing results (1201-1210 of 1,303) with videos related to
Sort By:
Page
of 131
The Lancet. Neurology
|
May 31, 2014
Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial
Adam L Boxer, Anthony E Lang, Murray Grossman, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
February 8, 2024
Plasma biomarkers of Alzheimer's disease in the continuum of dementia with Lewy bodies
Patricia Diaz-Galvan, Scott A Przybelski, Alicia Algeciras-Schimnich, et al.
Neurology
|
May 18, 2023
β-Amyloid Load on PET Along the Continuum of Dementia With Lewy Bodies
Patricia Diaz-Galvan, Scott A Przybelski, Timothy G Lesnick, et al.
Clinical Pharmacology and Therapeutics
|
July 7, 2021
Adverse Cardiovascular Outcomes and Antihypertensive Treatment: A Genome-Wide Interaction Meta-Analysis in the International Consortium for Antihypertensive Pharmacogenomics Studies
Caitrin W McDonough, Helen R Warren, John R Jack, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
February 11, 2026
AI-enhanced Centiloid quantification of amyloid PET images
Pierrick Bourgeat, Jurgen Fripp, Leo Lebrat, et al.
JAMA Neurology
|
September 15, 2025
Plasma Phosphorylated Tau 217 to Identify Preclinical Alzheimer Disease
Gemma Salvadó, Shorena Janelidze, Divya Bali, et al.
Acta Neuropathologica
|
March 13, 2024
Role of GBA variants in Lewy body disease neuropathology
Ronald L Walton, Shunsuke Koga, Alexandra I Beasley, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 1, 2024
Prediction of future cognitive decline among cognitively unimpaired individuals using measures of soluble phosphorylated tau or tau tangle pathology
Rik Ossenkoppele, Gemma Salvadó, Shorena Janelidze, et al.
Nature Aging
|
March 29, 2025
Plasma p-tau217 and tau-PET predict future cognitive decline among cognitively unimpaired individuals: implications for clinical trials
Rik Ossenkoppele, Gemma Salvadó, Shorena Janelidze, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
March 26, 2016
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
Bruno Dubois, Harald Hampel, Howard H Feldman, et al.
Page
of 131